Vertex Pharmaceuticals Inc. buy BiotechBee
Start price
07.09.22
/
70%
€285.85
Target price
31.12.25
€400.00
Performance (%)
10.34%
End price
05.05.23
€315.40
Summary
This prediction ended on 05.05.23 with a price of €315.40. The prediction had a final performance of 10.34%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -4.658% | -4.658% | -16.392% | 40.835% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
According to BiotechBee what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 400,0